BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9131490)

  • 1. Clinicopathologic variables predictive of residual dysplasia after cervical conization.
    Schermerhorn TJ; Hodge J; Saltzman AK; Hackett TE; Sprance HE; Harrison TA
    J Reprod Med; 1997 Apr; 42(4):189-92. PubMed ID: 9131490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia.
    Barlin JN; Bristow RE; Murillo AM; Zahurak M; Veras E; Salani R
    J Reprod Med; 2010; 55(3-4):129-33. PubMed ID: 20506673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cone margins as a predictor for residual dysplasia in post-cone hysterectomy specimens.
    Phelps JY; Ward JA; Szigeti J; Bowland CH; Mayer AR
    Obstet Gynecol; 1994 Jul; 84(1):128-30. PubMed ID: 8008307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
    Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
    Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-conization endocervical curettage for estimating the risk of persistent or recurrent high-grade dysplasia.
    Shaco-Levy R; Meirovitz M; Eger G; Benharroch D; Dreiher J
    Int J Gynaecol Obstet; 2013 Apr; 121(1):49-52. PubMed ID: 23332656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications, sequellae and outcome of cervical conizations: evaluation of three surgical technics].
    Brun JL; Youbi A; Hocké C
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):558-64. PubMed ID: 12407327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer.
    Fine BA; Feinstein GI; Sabella V
    Gynecol Oncol; 1998 Oct; 71(1):46-9. PubMed ID: 9784317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endocervical curettage at cervical conization for high-grade dysplasia.
    Kobak WH; Roman LD; Felix JC; Muderspach LI; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1995 Feb; 85(2):197-201. PubMed ID: 7824230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervical pathology: significance and therapeutic impact of margin status].
    Michy T; Leveque J; Loussouarn D; Dravet F; Dejode M; Sagan C; Descamps P; Classe JM
    Bull Cancer; 2008 Dec; 95(12):1171-5. PubMed ID: 19091650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.
    Roman LD; Felix JC; Muderspach LI; Agahjanian A; Qian D; Morrow CP
    Obstet Gynecol; 1997 Nov; 90(5):759-64. PubMed ID: 9351760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure.
    Brockmeyer AD; Wright JD; Gao F; Powell MA
    Am J Obstet Gynecol; 2005 May; 192(5):1379-81. PubMed ID: 15902114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer.
    Wong AS; Li WH; Cheung TH
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():21-6. PubMed ID: 26894378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Abnormal Precone Endocervical Curettage Result Is an Independent Risk Factor for Positive Margins in Conization Specimens.
    An J; Lei H; Xie X; Sun P
    Oncol Res Treat; 2020; 43(10):518-525. PubMed ID: 32772026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.